Anja Lunze | Taylor Wessing

Munich Germany

Contact Me Today

Email me Call me

Featured award

JUVE Awards 2023

Law firm of the year for IP Law

Anja heads our Life Sciences & Healthcare group in Germany. She is a specialist lawyer for intellectual property law, admitted as representative before the Unified Patent Court (UPC) and has specialized in patent law for 20 years. Anja manages and coordinates complex, multinational patent infringement proceedings and drafts infringement and nullity opinions. Further, she negotiates license as well as research and development negotiations.

She advises on parallel opposition and nullity proceedings before the European Patent Office, the Federal Patent Court and the Federal Supreme Court. In particular, Anja represents clients from the fields of pharmaceuticals, biotech, personalised medicine and precision medicine as well as from the chemical and medical device industries and advises on related issues of digitisation. Having spent time in Geneva, Strasbourg, Tokyo and London, Anja has intercultural competence and language skills (including English, French and Japanese).

Coffee Break Life Sciences Start-ups | Our new webinar series

Every third Wednesday of the month in 2024.

Sign up now!

The Unified Patent Court (UPC)

The UPC and Unitary Patent will introduce the most radical changes to patent litigation in Europe in 40 years.

Read our guide to the UPC

CV

2019 Mentorin women, IP e.V.

Since 2011 Lawyer, Taylor Wessing

Since 2011 Lecturer, Munich Business School

Career

2019 Mentorin women, IP e.V.

Since 2011 Lawyer, Taylor Wessing

Since 2011 Lecturer, Munich Business School

Education

2009 Specialist lawyer for Industrial Property Law

2006 Doctoral degree, summa cum laude, Ph.D. thesis on the "Legal consequences of patent invalidity. Analysis of German, French and U.S. American Law”, which was awarded the Faculty of Law Doctoral Prize at the Technical University of Dresden in 2007, Technical University Dresden

2006 Admitted as a lawyer, Düsseldorf

Publications

Einschränkungen der Patentinhaber im Bereich versorgungsrelevanter Produkte:
Zwangslizenzen, Enteignung und Entschädigungsansprüche, in: PharmR, mit Jan Phillip Rektorschek, 4/12/2021

Im Gespräch über Patentschutz für Corona-Impfstoff mit SWR2, 02/2021

Prozesskommentar Gewerblicher Rechtsschutz, in: 2. Auflage C.H. Beck, 2018, §§ 704 - 857 ZPO

Rechtsfolgen des Fortfalls des Patents, in: Nomos, 2007

Kommentar Gewerblicher Rechtsschutz, in: 3. Auflage Heymanns 2018, §§ 16, S. 20 - 23, S. 70 - 87 PatG

Patent Transactions in the Life Sciences - A Global Guide to Agreements in the Sector, in: 1. Auflage Globe Law and Business, 2014

Handbuch des Fachanwalts Gewerblicher Rechtsschutz, in: 3. Auflage Heymanns, 2018

Mind the injunction gap - focus on unified patent court, in: Intellectual Property Magazine, 04/2014

A doctrine of equivalents in the UPC?, in: The Patent Lawyer, 2013

Second medical use or indication claims, in: GRUR Int 2014, p. 906

Relief in IP Proceedings other than injunction and damages, in: GRUR Int, 2013, p. 773

Überprotektion durch Geistiges Eigentum?, in: Nomos, 2009

Memberships & Associations

German Association of Industrial Property Law and Copyright Law (GRUR)

Association of Experts of Industrial Property Law (VPP)

International Association for the Protection of Intellectual Property (AIPPI)

German Japanese Lawyer’s Association (DJJV)

German Japanese Society (DJG)

European Women’s Management Development International Network (EWMD)

Women in IP e.V.

Additional languages

Awards

JUVE Awards 2023

Featured

Who's Who Legal 2024

Managing Intellectual Property – IP Stars 2024

IAM Patent 1000 Germany 2024

Anja's news & insights

View Anja's insights

Click here to find out more

Competition, EU & trade

Taylor Wessing advises DEUTZ AG on its co-operation with the leading Indian agricultural machinery group TAFE Motors and Tractors Limited

12 August 2024

by multiple authors

Life sciences & healthcare

Early IP Strategy for Life Sciences Start-Ups Pays off

We explain the 5 biggest pitfalls

22 March 2024

Briefing

by Dr. Anja Lunze, LL.M. and Tobias Baus, LL.M., Dipl.-Ing.

Click here to find out more

Life sciences & healthcare

Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2

23 February 2024

In-depth analysis

by Dr. Anja Lunze, LL.M. and Tobias Baus, LL.M., Dipl.-Ing.

Click here to find out more